Prawo i regulacje · 13/02/2014

DEA Proposes to Schedule Suvorexant as a Schedule IV Controlled Substance

The Drug Enforcement Administration (DEA) is proposing to place the substance suvorexant into Schedule IV of the Controlled Substances Act (CSA), which would impose regulatory controls and sanctions on those who handle the substance, following a formal rulemaking process.